P16-10. IL-2 therapy mediates expansion of Treg cells, maintains IL-17 expressing CD4+ T-cells and selectively suppresses HIV specific T-cell responses
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
P16-10. IL-2 therapy mediates expansion of Treg cells, maintains IL-17 expressing CD4+ T-cells and selectively suppresses HIV specific T-cell responses ; volume:6 ; number:3 ; day:22 ; month:10 ; year:2009 ; pages:1 ; date:10.2009
Retrovirology ; 6, Heft 3 (22.10.2009), 1, 10.2009
- Creator
-
Ndhlovu, L.
- Contributor
-
Sinclair, E.
Epling, L.
Tan, QX
Ho, T.
Jha, AR
Levy, JA
Nixon, DF
Barbour, JD
Hecht, FM
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-6-S3-P239
- URN
-
urn:nbn:de:1111-201608079497
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ndhlovu, L.
- Sinclair, E.
- Epling, L.
- Tan, QX
- Ho, T.
- Jha, AR
- Levy, JA
- Nixon, DF
- Barbour, JD
- Hecht, FM
- SpringerLink (Online service)
Other Objects (12)
IL-21-Mediated Immunometabolic Modulation of T-Cells
Adenosine signaling in human T-cells favors development of IL-17⁺ cells and induces immunoregulatory characteristics
IL-17 producing CD4+CD45RO+ T-cells in atherosclerosis express GITR molecule
Rhythmic IL-17 production by γδ T cells maintains adipose de novo lipogenesis
Mucosal t-cells : 10 tables
Evolution of Vγ9Vδ2 T-cells
IL-22 production of effector CD4+ T-cells is altered in SLE patients
Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus
IL-23R + γδ [gamma-delta] T-cells : a population of effector cells that is pre-programmed in the embryonic thymus and enhances autoimmunity by restraining Foxp3 + regulatory T-cells
Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer
Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
A search for allorestricted T-cells
IL-21-Mediated Immunometabolic Modulation of T-Cells
Adenosine signaling in human T-cells favors development of IL-17⁺ cells and induces immunoregulatory characteristics
IL-17 producing CD4+CD45RO+ T-cells in atherosclerosis express GITR molecule
Rhythmic IL-17 production by γδ T cells maintains adipose de novo lipogenesis
Mucosal t-cells : 10 tables
Evolution of Vγ9Vδ2 T-cells
IL-22 production of effector CD4+ T-cells is altered in SLE patients
Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus
IL-23R + γδ [gamma-delta] T-cells : a population of effector cells that is pre-programmed in the embryonic thymus and enhances autoimmunity by restraining Foxp3 + regulatory T-cells
Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer
Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
A search for allorestricted T-cells
IL-21-Mediated Immunometabolic Modulation of T-Cells
Adenosine signaling in human T-cells favors development of IL-17⁺ cells and induces immunoregulatory characteristics
IL-17 producing CD4+CD45RO+ T-cells in atherosclerosis express GITR molecule
Rhythmic IL-17 production by γδ T cells maintains adipose de novo lipogenesis
Mucosal t-cells : 10 tables
Evolution of Vγ9Vδ2 T-cells
IL-22 production of effector CD4+ T-cells is altered in SLE patients
Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus
IL-23R + γδ [gamma-delta] T-cells : a population of effector cells that is pre-programmed in the embryonic thymus and enhances autoimmunity by restraining Foxp3 + regulatory T-cells
Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer
Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?